- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07949994
SALUTOGENESIS MODEL
The Effect of Salutogenesis-Based Care on Sense of Coherence and Functioning in Individuals With Bipolar Disorder
This study aims to examine the effect of nursing care based on the salutogenesis model on the sense of integrity and functionality levels in individuals with bipolar disorder. The scope of the study includes the evaluation of the effects of model-based care initiatives applied to individuals diagnosed with bipolar disorder on individuals' psychosocial adaptation, stress coping capacity and daily life functionality.
The study focuses on preventive and developmental care approaches in the field of mental health and disease nursing. The research is experimental in nature and will be carried out in an intervention and control group design. Within the scope of the study, structured nursing care based on the salutogenesis model will be applied to the intervention group, while routine care will be provided to the control group. The data will be collected through the sociodemographic information form, the sense of integrity scale and valid and reliable scales that measure the level of functionality in bipolar disorder. By comparing the pre-test and post-test measurements, the effect of the maintenance model will be analyzed using statistical methods. The original value of the study is that nursing care based on the salutogenesis model was considered experimentally for the first time in individuals diagnosed with bipolar disorder. Although the use of this model in chronic diseases is limited in the literature, there are no studies aimed at its application in psychiatric diseases, especially bipolar disorder. In this aspect, the research offers a unique contribution in terms of integrating a theoretical model into clinical nursing practice.
As a result of the study, it is predicted that care based on the salutogenesis model strengthens the sense of integrity of individuals and increases their level of functionality. It is expected that the findings to be obtained will contribute to psychiatric nursing practices, the development of care plans and the improvement of the quality of mental health services, the increase of professional satisfaction of mental health workers and the prevention of burnout problems.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sezgin Kılıç, PhD Student
- Phone Number: +90-5367004205
- Email: sezar5184@hotmail.com
Study Locations
-
-
-
Niğde, Turkey (Türkiye), 51200
- Recruiting
- Niğde Ömer Halisdemir Eğitim ve Araştırma hastanesi
-
Contact:
- Sezgin Kılıç
- Phone Number: 05367004205
- Email: sezar5184@hotmail.com
-
-
Niğde Province
-
Niğde, Niğde Province, Turkey (Türkiye), 51200
- Not yet recruiting
- Niğde Ömer Halisdemir Training and Research hospital, NIĞDE, Niğde 51200
-
Contact:
- Sezgin Kılıç
- Phone Number: +905367004205
- Email: sezar5184@hotmail.com
-
Contact:
- Sezgin Kılıç
- Phone Number: 05367004205
- Email: sezar5184@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all individuals diagnosed with bipolar disorder over the age of 18, who are not in an active illness attack with intelligence and meaning skills, who accepted the study.
Exclusion Criteria:
- people under the age of 18 who are in an active illness attack, have problems with understanding and intelligence, do not accept research.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Within the scope of the study, Certification maintenance application can be performed based on the variable series salutogenesis model, while routine maintenance can be performed in the control group. Organization of routine 4-session maintenance service of the control group. |
|
|
Experimental: The Universe and Sample of the Research
The universe of the research will be composed of patients diagnosed with bipolar disorder admitted to psychiatric outpatient clinics of Niğde Ömer Halisdemir Training and Research Hospital within the date December determined for the scientific study. The sample size of the study was determined by Uzdil et al. based on the effect size obtained from the (2022) study, it was calculated with the G*Power 3.1.9.2 program. In the analyses, the effect size was taken as d = 0.90, the confidence level α = 0.05 and the test strength (1-β) = 0.95 for two independent groups. According to the a priori power analysis, it was determined that a total of 68 people were needed in each group, including at least 34 participants. Taking into account the possible losses, it was planned to conduct the research with a total of 70 people, including 35 participants in each group. |
Care Guide Adapted from the Salutogenesis Model for Patients with Bipolar Disorder |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sense of Coherence Score
Time Frame: At baseline, 3 months after baseline, and 6 months after baseline.
|
Sense of coherence will be assessed using the Sense of Coherence Scale. The effect of salutogenesis model-based nursing care on the sense of coherence of individuals with bipolar disorder will be evaluated by comparing changes in scores between the intervention and control groups across three assessment points. |
At baseline, 3 months after baseline, and 6 months after baseline.
|
|
Change in Functionality Score
Time Frame: At baseline, 3 months after baseline, and 6 months after baseline.
|
Functionality will be assessed using the Bipolar Disorder Functioning Questionnaire. The effect of salutogenesis model-based nursing care on the functionality of individuals with bipolar disorder will be evaluated by comparing changes in scores between the intervention and control groups across three assessment points. |
At baseline, 3 months after baseline, and 6 months after baseline.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22504254-050.04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
I will decide when the data reaches maturity
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.